2.60
-0.01(-0.38%)
Currency In USD
| Previous Close | 2.61 |
| Open | 2.62 |
| Day High | 3.23 |
| Day Low | 2.58 |
| 52-Week High | 7.4 |
| 52-Week Low | 1.26 |
| Volume | 16.07M |
| Average Volume | 4.05M |
| Market Cap | 586.44M |
| PE | -2.95 |
| EPS | -0.88 |
| Moving Average 50 Days | 2.06 |
| Moving Average 200 Days | 2.79 |
| Change | -0.01 |
If you invested $1000 in Sana Biotechnology, Inc. (SANA) since IPO date, it would be worth $74.07 as of June 24, 2025 at a share price of $2.6. Whereas If you bought $1000 worth of Sana Biotechnology, Inc. (SANA) shares 3 years ago, it would be worth $370.9 as of June 24, 2025 at a share price of $2.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
GlobeNewswire Inc.
Yesterday at 2:05 PM GMT
Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Month Patient Follow-up Results Demonstrate that Sana’s Transplanted Pancreatic Islet Cells Modi
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
GlobeNewswire Inc.
Jun 09, 2025 8:05 PM GMT
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetesSEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a compa
Sana Biotechnology to Present at June 2025 Investor Conferences
GlobeNewswire Inc.
May 28, 2025 8:05 PM GMT
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences